Professor Kevin Read 

Kevin is chair of Quantitative Pharmacology and Head of DMPK in the Drug Discovery Unit at the University of Dundee (DDU-UoD), Scotland, UK. He has extensive experience of early phase drug discovery, lead optimisation, project leadership and preclinical development gained from over 30 years in the pharmaceutical industry at GlaxoSmithKline (UK and Verona, Italy) and in the DDU-UoD. As a DMPK leader, with particular expertise in CNS and anti-infective drug discovery, Kevin has achieved a considerable track record of success, playing a significant part in 11 compounds entering pre-clinical development, 8 of which have entered clinical trials.  Kevin is currently a lead investigator on a number of active grants and in partnership with major Pharma companies, with a focus on delivery of small molecule drug development candidates for Chagas disease, malaria, tuberculosis, schistosomiasis and cryptosporidiosis.

Come have a lunch with us and meet two ACS editors in another edition of ACS on Campus: Lori Ferrins – Topic Editor, Journal of Medicinal Chemistry; and Carolina Horta – Associate Editor, ACS Omega. The event will be part of 11th BrazMedChem and 9th BCNP programs. We will discuss valuable tips on how to prepare your manuscript in an efffective way as well as what our editors expect about an impactful paper. In addition, we will talk about Open Access and its impact on the visibility and democratization of scientific knowledge. The ACS on Campus will be held on Oct 25 at 12 PM (local time). All attendees will recieve a lunch box and a certificate. Register here: cvent.me/4K1qLP #ACSonCampus